United States · FDA National Drug Code directory
Thalomid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59572-205_58b287d1-24f5-4dfe-84ca-898a8a5b9302
- Product NDC
- 59572-205
- Form
- CAPSULE
- Composition / generic term
- Thalidomide
- Labeler
- Celgene Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20030620
- Source listing expiry
- 20261231
Source-listed ingredients
- THALIDOMIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 BOX (59572-205-94) / 28 CAPSULE in 1 BLISTER PACK (59572-205-14) · 59572-205-94
- 10 BLISTER PACK in 1 BOX (59572-205-97) / 1 CAPSULE in 1 BLISTER PACK (59572-205-17) · 59572-205-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →